GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Debt-to-Equity

ClouDr Group (HKSE:09955) Debt-to-Equity : 0.15 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Debt-to-Equity?

ClouDr Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$256 Mil. ClouDr Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$36 Mil. ClouDr Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,997 Mil. ClouDr Group's debt to equity for the quarter that ended in Dec. 2023 was 0.15.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ClouDr Group's Debt-to-Equity or its related term are showing as below:

HKSE:09955' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.27   Med: -0.11   Max: 0.15
Current: 0.15

During the past 5 years, the highest Debt-to-Equity Ratio of ClouDr Group was 0.15. The lowest was -1.27. And the median was -0.11.

HKSE:09955's Debt-to-Equity is ranked better than
65.06% of 83 companies
in the Medical Distribution industry
Industry Median: 0.29 vs HKSE:09955: 0.15

ClouDr Group Debt-to-Equity Historical Data

The historical data trend for ClouDr Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Debt-to-Equity Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
-0.31 -0.11 -1.27 0.12 0.15

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial -1.27 -0.01 0.12 0.17 0.15

Competitive Comparison of ClouDr Group's Debt-to-Equity

For the Medical Distribution subindustry, ClouDr Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ClouDr Group's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ClouDr Group's Debt-to-Equity falls into.


ClouDr Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ClouDr Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(255.618 + 36.476) / 1996.507
=0.15

ClouDr Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(255.618 + 36.476) / 1996.507
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ClouDr Group  (HKSE:09955) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

ClouDr Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ClouDr Group (HKSE:09955) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Debt-to-Equity
Comparable Companies
HKSE:01931 HKSE:02192 HKSE:00314 HKSE:02289 HKSE:00673 HKSE:06833 HKSE:00718 HKSE:08372 HKSE:00401 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784
Traded in Other Exchanges
H3L:Germany
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.cloudr.cn
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines